Dr David Kurtz discusses in this podcast the most recent technical developments and practical applications of circulating tumor DNA and liquid biopsies, an active area of research in the last 25 years, which is now gaining more importance and translational application in the clinic. In tumors like B-cell non-Hodgkin lymphomas, for example, somatic mutations can now be tracked and diagnosed using these techniques. Other fields of active investigations include CLL and solid tumors, as well as disease monitoring and early diagnosis on relapses.Host: Shaun McCann; Guest: Dr. David KurtzWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more eLearning or podcasts? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Dr David Kurtz discusses in this podcast the most recent technical developments and practical applications of circulating tumor DNA and liquid biopsies, an active area of research in the last 25 years, which is now gaining more importance and translational application in the clinic. In tumors like B-cell non-Hodgkin lymphomas, for example, somatic mutations can now be tracked and diagnosed using these techniques. Other fields of active investigations include CLL and solid tumors, as well as disease monitoring and early diagnosis on relapses. Host: Shaun McCann; Guest: Dr. David Kurtz What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Circulating Tumor DNA

The whole world of CML changed in the early 2000s with the introduction of imatinib and TKIs, however, the situation in developing countries can be significantly different from Europe and USA, as discussed by Prof Hemant Malhotra in this podcast. Short-backs may encompass the molecular diagnosis and monitoring of the disease (not everywhere available) as well as the cost of drugs and medical expense coverage. On the other hand, the relative affordability of generic TKIs may cause skipping of expensive diagnostic procedures before starting treatment, whereas their current prolonged life expectancy is making the number of CML patients increasingly high. A complex picture that is worth listening to in order to better understand medicine across different regions in the world.Host: Shaun McCann; Guest: Prof. Hemant MalhotraWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more eLearning or podcasts? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

The whole world of CML changed in the early 2000s with the introduction of imatinib and TKIs, however, the situation in developing countries can be significantly different from Europe and USA, as discussed by Prof Hemant Malhotra in this podcast. Short-backs may encompass the molecular diagnosis and monitoring of the disease (not everywhere available) as well as the cost of drugs and medical expense coverage. On the other hand, the relative affordability of generic TKIs may cause skipping of expensive diagnostic procedures before starting treatment, whereas their current prolonged life expectancy is making the number of CML patients increasingly high. A complex picture that is worth listening to in order to better understand medicine across different regions in the world. Host: Shaun McCann; Guest: Prof. Hemant Malhotra What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Treating CML in Developing Countries

Transfusion processes have changed significantly in recent years, at the same time changing the guidelines for blood cell replacement therapy. Listen to Prof. Michael Murphy in this podcast as he provides an overview of the most up-to-date topics in transfusion, including the relevant risk of over-transfusion, restricted transfusion practices, and also the issues of delayed transfusion and transfusion-related infections. "Don't give two when one will do," should remain the bottom line criterion in transfusion decisions in stable patients.Host: Shaun McCann; Guest: Prof. Michael MurphyWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more eLearning or podcasts? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Transfusion processes have changed significantly in recent years, at the same time changing the guidelines for blood cell replacement therapy. Listen to Prof. Michael Murphy in this podcast as he provides an overview of the most up-to-date topics in transfusion, including the relevant risk of over-transfusion, restricted transfusion practices, and also the issues of delayed transfusion and transfusion-related infections. "Don't give two when one will do," should remain the bottom line criterion in transfusion decisions in stable patients. Host: Shaun McCann; Guest: Prof. Michael Murphy What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Less is More - Transfusion

This podcast follows a short discussion between two young hematologists on a clinical case review of a chronic myeloid leukemia patient called Naomi. In this discussion, the hematologists go through Naomi’s case while addressing the management of CML patients in complete molecular response and the requirements for discontinuation of tyrosine kinase treatment in CML patients. This podcast is rendered from QR Case 5 - Chronic Myeloid Leukemia (Naomi) on the EHA Campus. What did you think of this podcast? Share your opinions with us in this short feedback survey. Provide FeedbackWould you like to explore more podcasts or clinical cases? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

This podcast follows a short discussion between two young hematologists on a clinical case review of a chronic myeloid leukemia patient called Naomi. In this discussion, the hematologists go through Naomi’s case while addressing the management of CML patients in complete molecular response and the requirements for discontinuation of tyrosine kinase treatment in CML patients. This podcast is rendered from QR Case 5 - Chronic Myeloid Leukemia (Naomi) on the EHA Campus. What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more podcasts or clinical cases? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Chronic Myeloid Leukemia (Naomi)

In the sixth episode of the Clinical Trial podcast series, Prof. Robert Hills discusses the different reasons that lead to the end of a trial – especially when it is earlier than planned. He also gives us a summary of what happens after the trial; the importance of some steps involving the data and their availability, and the writing of reports for the appropriate regulatory authorities. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as:• What is a CRO?• How are clinical studies designed?• Which role(s) should sponsors fulfil?Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts.Host: Prof. Robert HillsWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the sixth episode of the Clinical Trial podcast series, Prof. Robert Hills discusses the different reasons that lead to the end of a trial – especially when it is earlier than planned. He also gives us a summary of what happens after the trial; the importance of some steps involving the data and their availability, and the writing of reports for the appropriate regulatory authorities. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as: • What is a CRO? • How are clinical studies designed? • Which role(s) should sponsors fulfil? Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts. Host: Prof. Robert Hills What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

All Good Things Must Come to an End: How and When to End a Clinical Trial (Clinical Trial)

In the fourth episode of the EHA Diagnosing And Treating Iron Deficiency podcast series, host Prof Gunnar Birgegård and guest expert Prof Antonio Almeda discuss the diagnostic and therapeutic management of iron deficiency and anemia in the perioperative setting, a clinical situation where having inadequate iron stores carries significant clinical consequences on mortality and morbidity outcomes. They also address the conclusions of different studies that have investigated the impact of repleting patients with iron on the incidence of complications, mortality, or long-term health. They also disclose how they are monitoring their patients’ iron levels following surgery and why it is important.Host: Prof Gunnar Birgegård; Guest: Prof Antonio AlmedaWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the fourth episode of the EHA Diagnosing And Treating Iron Deficiency podcast series, host Prof Gunnar Birgegård and guest expert Prof Antonio Almeda discuss the diagnostic and therapeutic management of iron deficiency and anemia in the perioperative setting, a clinical situation where having inadequate iron stores carries significant clinical consequences on mortality and morbidity outcomes. They also address the conclusions of different studies that have investigated the impact of repleting patients with iron on the incidence of complications, mortality, or long-term health. They also disclose how they are monitoring their patients’ iron levels following surgery and why it is important. Host: Prof Gunnar Birgegård; Guest: Prof Antonio Almeda What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Iron Deficiency: Perioperative

In the fifth episode of the Clinical Trial podcast series, Prof. Robert Hills discusses the documentation of clinical trials and how it represents a safeguard for the credibility of the trial. He points out the importance of finding a good balance between too many documents and not enough of them. In addition, he highlights the multitude of different groups working on a clinical trial, which ultimately renders documentation an insurance to a smooth process. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as:• What is a CRO?• How are clinical studies designed?• Which role(s) should sponsors fulfil?Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts.Host: Prof. Robert HillsWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the fifth episode of the Clinical Trial podcast series, Prof. Robert Hills discusses the documentation of clinical trials and how it represents a safeguard for the credibility of the trial. He points out the importance of finding a good balance between too many documents and not enough of them. In addition, he highlights the multitude of different groups working on a clinical trial, which ultimately renders documentation an insurance to a smooth process. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as: • What is a CRO? • How are clinical studies designed? • Which role(s) should sponsors fulfil? Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts. Host: Prof. Robert Hills What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Documentation and authorization: Safeguarding the Credibility of Clinical Trials (Clinical Trial)

In the fifth and final episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and guest experts Prof Raul Cordoba, Dr Ulrich Wedding, and Dr Dominique Bron discuss the ethical issues associated with treating hematological malignancies in older adults. They raise different points regarding treatment decisions made with (and not without) the patient and amongst other parameters, how much of an impact costs have in the choice of treatment. Dr Bron also reminds us of the 4 principles of healthcare (nonmaleficence, beneficence, autonomy, and justice) – and that age is not a criterion in deciding whether a patient should be treated or not. Finally, they address the impact of COVID-19 on the current clinical practice and whether it has exacerbated ethical issues. Host: Gareth Tucker; Guest: Prof Raul Cordoba, Dr Ulrich Wedding, Prof Dominique BronIn the second episode of the Aging Patient: Dispelling Myths podcast series, the importance of medical decision making based on a patient’s ‘fitness’ rather than their age will be stressed, and the impact of good diet and exercise in maintaining fitness and delaying sarcopenia highlighted.Host: Gareth Tucker; Guest: Prof Alessandra Tucci, Prof Sergio StortiWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the fifth and final episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and guest experts Prof Raul Cordoba, Dr Ulrich Wedding, and Dr Dominique Bron discuss the ethical issues associated with treating hematological malignancies in older adults. They raise different points regarding treatment decisions made with (and not without) the patient and amongst other parameters, how much of an impact costs have in the choice of treatment. Dr Bron also reminds us of the 4 principles of healthcare (nonmaleficence, beneficence, autonomy, and justice) – and that age is not a criterion in deciding whether a patient should be treated or not. Finally, they address the impact of COVID-19 on the current clinical practice and whether it has exacerbated ethical issues. Host: Gareth Tucker; Guest: Prof Raul Cordoba, Dr Ulrich Wedding, Prof Dominique Bron In the second episode of the Aging Patient: Dispelling Myths podcast series, the importance of medical decision making based on a patient’s ‘fitness’ rather than their age will be stressed, and the impact of good diet and exercise in maintaining fitness and delaying sarcopenia highlighted. Host: Gareth Tucker; Guest: Prof Alessandra Tucci, Prof Sergio Storti What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Ethical Issues Associated with Treating Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)

In the fourth episode of the Clinical Trial podcasts, Dr. Eleftheria Hatzimichael gives us an overview of the sponsor's role and responsibilities in investigator-initiated clinical trials. The different meaning of "sponsor" and "funder", the importance for physicians to be involved in the design of clinical trials, the eight overarching responsibilities of the sponsor, are all key topics discussed in this podcast. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as:• What is a CRO?• How are clinical studies designed?• Which role(s) should sponsors fulfil?Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts.Host: Dr. Eleftheria HatzimichaelWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the fourth episode of the Clinical Trial podcasts, Dr. Eleftheria Hatzimichael gives us an overview of the sponsor's role and responsibilities in investigator-initiated clinical trials. The different meaning of "sponsor" and "funder", the importance for physicians to be involved in the design of clinical trials, the eight overarching responsibilities of the sponsor, are all key topics discussed in this podcast. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as: • What is a CRO? • How are clinical studies designed? • Which role(s) should sponsors fulfil? Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts. Host: Dr. Eleftheria Hatzimichael What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Sponsor: A Role to Take Seriously (Clinical Trial)

In the fourth episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and guest expert Prof Monica Engelhardt discuss how comprehensive geriatric assessment can guide treatment decisions and improve patient outcomes.Dr Engelhardt gives us an insight into her clinical practice and how elderly hematology patients are receptive - or not - to this testing. You will also learn what are the parameters to consider when treating elderly patients for hematologic malignancies, e.g., how frailty can influence the outcomes of the treatment. Finally, Dr Engelhardt addresses the current pandemic situation regarding these patients: are older patients more vulnerable to COVID-19 when they are already suffering from hematological malignancies and under treatment? Host: Gareth Tucker; Guest: Prof Monika EngelhardtWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the fourth episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and guest expert Prof Monica Engelhardt discuss how comprehensive geriatric assessment can guide treatment decisions and improve patient outcomes. Dr Engelhardt gives us an insight into her clinical practice and how elderly hematology patients are receptive - or not - to this testing. You will also learn what are the parameters to consider when treating elderly patients for hematologic malignancies, e.g., how frailty can influence the outcomes of the treatment. Finally, Dr Engelhardt addresses the current pandemic situation regarding these patients: are older patients more vulnerable to COVID-19 when they are already suffering from hematological malignancies and under treatment? Host: Gareth Tucker; Guest: Prof Monika Engelhardt What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Hematological Changes in Older Adults (Aging Patient: Dispelling Myths)

In these EHA-produced podcasts, experts share with you their hematology knowledge and stories. With "EHA Unplugged" we would like to give you the opportunity to unplug from your computer screen, while still learning, by listening to interviews, clinical cases, monologues, and more.

In the third episode of the Clinical Trial podcasts, Prof. Martin Dreyling from the University of Munich makes several points about standards of care in clinical studies, also mentioned as GCPs (Good Clinical Practices). He gives us a historical perspective on the establishment of these standards 20 years ago, and how they need an update through what he calls a ‘reality check’. Prof. Dreyling is part of the coalition Reducing Bureaucracy in Clinical Trials and explains what they are proposing to update and improve GCPs in 2021.In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as:• What is a CRO?• How are clinical studies designed?• Which role(s) should sponsors fulfil?Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts.Host: Prof. Martin DreylingWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the third episode of the Clinical Trial podcasts, Prof. Martin Dreyling from the University of Munich makes several points about standards of care in clinical studies, also mentioned as GCPs (Good Clinical Practices). He gives us a historical perspective on the establishment of these standards 20 years ago, and how they need an update through what he calls a ‘reality check’. Prof. Dreyling is part of the coalition Reducing Bureaucracy in Clinical Trials and explains what they are proposing to update and improve GCPs in 2021. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as: • What is a CRO? • How are clinical studies designed? • Which role(s) should sponsors fulfil? Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts. Host: Prof. Martin Dreyling What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Patient Support: Relate and Create (Clinical Trial)

In the third episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and experts Prof Antonio Almeida, Prof Valentin Goede, and Dr Annamaria Brioli discuss the treatment of hematological malignancies in older adults, involving polypharmacy in most cases. They describe how patients commonly react to polypharmacy and how challenging it can be to have all the information about a patient’s full list of medication, and to keep them compliant. They also address the step of deprescribing, a critical point in the therapy of these patients. Host: Gareth Tucker; Guest: Prof Valentin Goede, Prof Antonio Almeida, Dr Annamaria BrioliWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the third episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and experts Prof Antonio Almeida, Prof Valentin Goede, and Dr Annamaria Brioli discuss the treatment of hematological malignancies in older adults, involving polypharmacy in most cases. They describe how patients commonly react to polypharmacy and how challenging it can be to have all the information about a patient’s full list of medication, and to keep them compliant. They also address the step of deprescribing, a critical point in the therapy of these patients. Host: Gareth Tucker; Guest: Prof Valentin Goede, Prof Antonio Almeida, Dr Annamaria Brioli What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Treatment of Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)

PAPER

In the second episode of the Clinical Trial podcasts, former EHA President Prof. John Gribben gives us an overview of the role(s) of CROs (Contract Research Organizations) in clinical investigation. He discusses how they can help, notably with the paper trails associated with clinical trials, and how they should be constructive partners in the process of clinical research.In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as:• What is a CRO?• How are clinical studies designed?• Which role(s) should sponsors fulfil?Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts.Host: Prof. John Gribben What did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the second episode of the Clinical Trial podcasts, former EHA President Prof. John Gribben gives us an overview of the role(s) of CROs (Contract Research Organizations) in clinical investigation. He discusses how they can help, notably with the paper trails associated with clinical trials, and how they should be constructive partners in the process of clinical research. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as: • What is a CRO? • How are clinical studies designed? • Which role(s) should sponsors fulfil? Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts. Host: Prof. John Gribben What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

The Paper Trail (CRO) (Clinical Trial)

In the second episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker discusses with experts Prof Alessandra Tucci and Prof Sergio Storti the definition and importance of patient assessment (including frailty, comorbidity, and polypharmacy), in older adults with hematological conditions and how it can be used to determine the overall ‘fitness’ of a patient. They also discuss the critical role of interactions between HCPs, patients, and their entourage in the assessment.You will listen to clinical examples showing how a complete geriatric assessment can help direct treatment for older patients with specific hematological malignancies and how a benefit can be obtained from more effective, novel treatments.Host: Gareth Tucker; Guest: Prof Alessandra Tucci, Prof Sergio StortiAdditional information (in order of mention):  HCP: Healthcare ProfessionalCLL: Chronic Lymphocytic Leukemia11q minus: deletion of a portion of the long arm (q) of chromosome 11SF3B1 gene: Splicing Factor 3B1POT1 gene: Protection of Telomeres 1 AML: Acute myeloid leukemiaIPSS: International Prognostic Scoring SystemADL: Activities of Daily LivingIADL: Instrumental Activities of Daily LivingWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the second episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker discusses with experts Prof Alessandra Tucci and Prof Sergio Storti the definition and importance of patient assessment (including frailty, comorbidity, and polypharmacy), in older adults with hematological conditions and how it can be used to determine the overall ‘fitness’ of a patient. They also discuss the critical role of interactions between HCPs, patients, and their entourage in the assessment. You will listen to clinical examples showing how a complete geriatric assessment can help direct treatment for older patients with specific hematological malignancies and how a benefit can be obtained from more effective, novel treatments. Host: Gareth Tucker; Guest: Prof Alessandra Tucci, Prof Sergio Storti Additional information (in order of mention):  <ul><li>HCP: Healthcare Professional</li><li>CLL: Chronic Lymphocytic Leukemia</li><li>11q minus: deletion of a portion of the long arm (q) of chromosome 11</li><li>SF3B1 gene: Splicing Factor 3B1</li><li>POT1 gene: Protection of Telomeres 1 </li><li>AML: Acute myeloid leukemia</li><li>IPSS: International Prognostic Scoring System</li><li>ADL: Activities of Daily Living</li><li>IADL: Instrumental Activities of Daily Living</li></ul>What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Patient Assessment In Older Adults (Aging Patient: Dispelling Myths)

In this podcast, the last of a series dedicated to Multiple Myeloma in underserved patient populations with, Prof Sonja Zweegman focuses on the challenges associated with MM treatment in older patients, namely the assessment of frailty and how to adapt treatment in this population. The podcast also addresses the specific characteristics of MM in the elderly, including the incidence of genetic mutations and the role of comorbidities.  Speaker: Prof Sonja Zweegman; Host: Prof Pieter SonneveldWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us:  education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In this podcast, the last of a series dedicated to Multiple Myeloma in underserved patient populations with, Prof Sonja Zweegman focuses on the challenges associated with MM treatment in older patients, namely the assessment of frailty and how to adapt treatment in this population. The podcast also addresses the specific characteristics of MM in the elderly, including the incidence of genetic mutations and the role of comorbidities.  Speaker: Prof Sonja Zweegman; Host: Prof Pieter Sonneveld What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions. <a href="https://ehacampus.ehaweb.org/ehailp/pages/description.jsf?menuId=1422#/users/@self/catalogues/355089/courses/392645/description" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/</a> Facebook: <a href="https://e-h-a.link/facebook" rel="nofollow" target="_blank">https://e-h-a.link/facebook</a> LinkedIn: <a href="https://www.linkedin.com/company/eha/" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/</a> Email us:  education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Multiple Myeloma in Underserved Populations (Episode 3)

In the first episode of the Clinical Trial podcasts, Amsterdam UMC researcher and author of “A Quick Guide on How to Conduct Medical Research” Dr. Marieke Ter Wee points out the importance of formulating a research question at the beginning of any clinical trial. What models are used to formulate the question and answer to it? She unravels the main parts of a research proposal that should be elaborated by the authors of clinical studies.In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as:• What is a CRO?• How are clinical studies designed?• Which role(s) should sponsors fulfil?Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts.Host: Dr. Marieke ter WeeWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the first episode of the Clinical Trial podcasts, Amsterdam UMC researcher and author of “A Quick Guide on How to Conduct Medical Research” Dr. Marieke Ter Wee points out the importance of formulating a research question at the beginning of any clinical trial. What models are used to formulate the question and answer to it? She unravels the main parts of a research proposal that should be elaborated by the authors of clinical studies. In this series of Clinical Trial podcasts produced by EHA, experts unravel for you the many issues linked to the design and execution of a clinical study, complementing the information present in our Clinical Trial Map. It will help you answer interrogations such as: • What is a CRO? • How are clinical studies designed? • Which role(s) should sponsors fulfil? Experts will talk directly to you to give you an overview of several essential clinical research topics in a series of 6 podcasts. Host: Dr. Marieke ter Wee What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to explore more podcasts or check out the Clinical Trial Map? Please visit the EHA Campus. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

What matters in a trial design? (Clinical Trial)

In the Aging Patient: Dispelling Myths podcast series, Prof Raul Cordoba kicks off a series of podcasts that will offer you up-to-date information about hematology in older adults.For the first interview, he welcomes guest expert Dr Kristina Kirschner to discuss aging and clonal disease. You will learn how clonal hematopoiesis increases with advancing age and how the accumulation of some clonal mutations have been linked with hematological cancers. Dr Kirschner answers questions - asked by patients - about the definition of aging by hematologists, or the relation of aging and susceptibility to clonal cancers. They also address the mechanisms of epigenetic mutations in aging hematopoietic stem cells and the impact of genes drivers of myeloid malignancies in the elderly population.Host: Dr Raul Cordoba; Guest: Dr Kristina KirschnerAdditional information (in order of mention): AML (disease): Acute Myeloid LeukemiaMDS (disease): Myelodysplastic SyndromesDNMT3A gene (DNA Methyltransferase 3 Alpha)TET2 gene (Tet Methylcytosine Dioxygenase 2)ASXL1 gene (ASXL Transcriptional Regulator 1)CHIP (disease): (Clonal Hematopoiesis of Indeterminate Potential)PPM1D gene: Protein Phosphatase, Mg2+/Mn2+ Dependent 1DWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the Aging Patient: Dispelling Myths podcast series, Prof Raul Cordoba kicks off a series of podcasts that will offer you up-to-date information about hematology in older adults. For the first interview, he welcomes guest expert Dr Kristina Kirschner to discuss aging and clonal disease. You will learn how clonal hematopoiesis increases with advancing age and how the accumulation of some clonal mutations have been linked with hematological cancers.  Dr Kirschner answers questions - asked by patients - about the definition of aging by hematologists, or the relation of aging and susceptibility to clonal cancers. They also address the mechanisms of epigenetic mutations in aging hematopoietic stem cells and the impact of genes drivers of myeloid malignancies in the elderly population. Host: Dr Raul Cordoba; Guest: Dr Kristina Kirschner Additional information (in order of mention): <ul><li>AML (disease): Acute Myeloid Leukemia</li><li>MDS (disease): Myelodysplastic Syndromes</li><li>DNMT3A gene (DNA Methyltransferase 3 Alpha)</li><li>TET2 gene (Tet Methylcytosine Dioxygenase 2)</li><li>ASXL1 gene (ASXL Transcriptional Regulator 1)</li><li>CHIP (disease): (Clonal Hematopoiesis of Indeterminate Potential)</li><li>PPM1D gene: Protein Phosphatase, Mg2+/Mn2+ Dependent 1D</li></ul>What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the Aging Patient: Dispelling Myths program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Aging and Clonal Diseases (Aging Patient: Dispelling Myths)

In the third episode of the Iron Deficiency podcast series, host Prof Gunnar Birgegård and guest expert Dr Noemi Roy review the many important functions iron plays in the body, providing the background for the high prevalence of iron deficiency in women, particularly in their fertile life and during pregnancies. They address different strategies of treatment, including IV, oral treatment, and nutrition recommendations. Finally, they also highlight the importance of treating iron deficiency after childbirth when the mother comes back home.Host: Prof Gunnar Birgegård; Guest: Dr Noemi RoyWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the third episode of the Iron Deficiency podcast series, host Prof Gunnar Birgegård and guest expert Dr Noemi Roy review the many important functions iron plays in the body, providing the background for the high prevalence of iron deficiency in women, particularly in their fertile life and during pregnancies. They address different strategies of treatment, including IV, oral treatment, and nutrition recommendations. Finally, they also highlight the importance of treating iron deficiency after childbirth when the mother comes back home. Host: Prof Gunnar Birgegård; Guest: Dr Noemi Roy What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Iron Deficiency: Women

In the second episode of the EHA Diagnosing And Treating Iron Deficiency podcast series, host Prof Gunnar Birgegård and guest expert Prof Christopher Winearls highlight the high prevalence of iron deficiency anemia in patients with CKD, together with its association with poor long-term outcomes. They discuss the importance of monitoring iron on top of monitoring erythropoietin and treating the deficiency prior to the use of erythropoietin. Overall, Prof Winearls discloses how to evaluate ferritin and Hb levels in CKD patients and how to treat iron deficiency and monitor outcomes in this special population.  Host: Prof Gunnar Birgegård; Guest: Prof Christopher WinearlsAdditional information (in order of mention): CKD (disease): Chronic Kidney DiseaseHIF PH (treatment): Hypoxia-Inducible Factor Prolyl Hydroxylase enzyme inhibitorsWhat did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the second episode of the EHA Diagnosing And Treating Iron Deficiency podcast series, host Prof Gunnar Birgegård and guest expert Prof Christopher Winearls highlight the high prevalence of iron deficiency anemia in patients with CKD, together with its association with poor long-term outcomes. They discuss the importance of monitoring iron on top of monitoring erythropoietin and treating the deficiency prior to the use of erythropoietin. Overall, Prof Winearls discloses how to evaluate ferritin and Hb levels in CKD patients and how to treat iron deficiency and monitor outcomes in this special population.  Host: Prof Gunnar Birgegård; Guest: Prof Christopher Winearls Additional information (in order of mention): CKD (disease): Chronic Kidney DiseaseHIF PH (treatment): Hypoxia-Inducible Factor Prolyl Hydroxylase enzyme inhibitors What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Iron Deficiency: Chronic Kidney Disease

In the first episode of the EHA Diagnosing And Treating Iron Deficiency podcast series, Prof Gunnar Birgegård and host expert Prof Antonio Almeida define what is iron deficiency and more precisely functional iron deficiency. They discuss the prevalence of anemia in cardiac failure patients and the relation between severity of the heart disease and incidence of iron deficiency. They also highlight the importance of monitoring potential renal symptoms for better treatment outcomes.Host: Prof Gunnar Birgegård; Guest: Prof Antonio AlmeidaThis episode was produced with the support of the World Heart Federation.What did you think of this podcast? Share your opinions with us in this short feedback survey.Provide FeedbackWould you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program.https://ehaedu.org/CampusSubscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/Facebook: https://e-h-a.link/facebookLinkedIn: https://www.linkedin.com/company/eha/Email us: education@ehaweb.orgSubscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In the first episode of the EHA Diagnosing And Treating Iron Deficiency podcast series, Prof Gunnar Birgegård and host expert Prof Antonio Almeida define what is iron deficiency and more precisely functional iron deficiency. They discuss the prevalence of anemia in cardiac failure patients and the relation between severity of the heart disease and incidence of iron deficiency. They also highlight the importance of monitoring potential renal symptoms for better treatment outcomes. Host: Prof Gunnar Birgegård; Guest: Prof Antonio Almeida This episode was produced with the support of the World Heart Federation. What did you think of this podcast? Share your opinions with us in this short feedback survey. <a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1" rel="nofollow" target="_blank">Provide Feedback</a> Would you like to receive EBAH CME credit points for listening to this podcast? Please visit the EHA Campus and finalize the quiz questions in the EHA Diagnosing And Treating Iron Deficiency Program. <a href="https://ehacampus.ehaweb.org/" rel="nofollow" target="_blank">https://ehaedu.org/Campus</a> Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.instagram.com/EHA_Hematology/ </a>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://e-h-a.link/facebook </a>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://www.linkedin.com/company/eha/ </a>Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&amp;utm_source=bcast&amp;utm_campaign=eha-unplugged" rel="nofollow" target="_blank">https://eha.news/subscribe</a>

Iron Deficiency: Heart Failure

EHA Unplugged

The best podcasts on investing. For anyone interested in the stories in the investing industry, whether it's an interview with Ray Dalio or Ed Thorp to the writer of The Big Short. This topic includes the most fascinating stories from all the best investors. Add episodes you're interested into your queue below!

Best Investing Podcasts

The best episodes for anyone looking to learn more about topics such as happiness, fulfillment, depression and psychology/mental health in general. With interviews with industry experts, personal stories of individuals, this topic has lessons applicable to everyone. Add episodes you're interested into your queue below!